CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR MUCINOUS TUMORS OF THE GASTROINTESTINAL TRACT

Keyphrases

• Gastrointestinal Tract 100%
• Cytoreductive Surgery 100%
• Mucinous Tumor 100%
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 100%
• Mucinous 50%
• Peritoneal Cavity 50%
• Peritoneal Membrane 50%
• Carcinomatosis 50%
• Abdominal 25%
• Surgeons 25%
• Treatment Strategy 25%
• Chemotherapy 25%
• Low-grade Malignancy 25%
• Therapeutic Potential 25%
• Disease Mechanisms 25%
• Treatment Options 25%
• Patient Demographics 25%
• Improved Survival 25%
• Large Potential 25%
• Flow Pattern 25%
• Peritoneum 25%
• Abdomen 25%
• Pathologic Processes 25%
• Disease Spread 25%
• Standardized Method 25%
• Peritoneal Fluid 25%
• Combined Modality Therapy 25%
• Lymphatic System 25%
• Vascular System 25%
• Peritoneal Metastasis 25%
• Colorectal Cancer Metastases 25%
• Lymph Flow 25%
• Peritoneal Carcinomatosis 25%
• Surgical Treatment Options 25%
• Primary Peritoneal Cancer 25%
• Cancer Dissemination 25%
• Peritoneal Tumor 25%
• Peritoneal Cancer Metastases 25%
• Gastric Metastasis 25%
• Potential Space 25%

Medicine and Dentistry

• Metastatic Carcinoma 100%
• Gastrointestinal Tract 100%
• Cytoreductive Surgery 100%
• Mucinous Tumor 100%
• Hyperthermic Intraperitoneal Chemotherapy 100%
• Diseases 75%
• Carcinosis 50%
• Peritoneal Cavity 50%
• Treatment Option 50%
• Cancer 25%
• Patient Population 25%
• Colorectal Carcinoma 25%
• Physical Disease by Body Function 25%
• Peritoneal Fluid 25%
• Lymph Duct 25%
• Peritoneum 25%
• Abdominal Cancer 25%
• Vascular System 25%
• Peritoneum Metastasis 25%
• Lymph Flow 25%
• Carcinomatous Peritonitis 25%
• Primary Peritoneal Cancer 25%
• Peritoneum Tumor 25%
• Potential Space 25%
• Experienced Surgeon 25%